Status:

COMPLETED

A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Non-Hodgkin's Lymphoma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This two-stage, multi-center, randomized, controlled, open-label study will investigate the pharmacokinetics, efficacy and safety of rituximab SC versus rituximab IV in participants with previously un...

Eligibility Criteria

Inclusion

  • Cluster of differentiation 20 (CD20)-positive, follicular Non-Hodgkin's lymphoma grade 1, 2, 3a. A tumor biopsy must have been performed within 6 months before study entry with material available for central review
  • No prior treatment
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2

Exclusion

  • Grade 3b follicular lymphoma
  • Transformation to high-grade lymphoma secondary to follicular lymphoma
  • Types of Non-Hodgkin's lymphoma other than follicular lymphoma
  • Presence or history of central nervous system (CNS) disease
  • Corticoid therapy during the last 4 weeks, except prednisone treatment less than (\<) 20 milligrams per day (mg per day)
  • Known active bacterial, viral, fungal, or mycobacterial, or any major episode of infections requiring hospitalization or treatment with IV antibiotics within 4 weeks of start of study medication, or oral antibiotics within 2 weeks prior to start of study medication

Key Trial Info

Start Date :

February 15 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2017

Estimated Enrollment :

410 Patients enrolled

Trial Details

Trial ID

NCT01200758

Start Date

February 15 2011

End Date

October 31 2017

Last Update

November 27 2018

Active Locations (152)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 38 (152 locations)

1

Gosford Hospital; Cancer Care Services

Gosford, New South Wales, Australia, 2250

2

Wollongong Hospital; Cancer Services

Wollongong, New South Wales, Australia, 2500

3

Royal Brisbane and Women's Hospital

Herston, Queensland, Australia, 4029

4

Gold Coast Hospital; Haematology Department

Southport, Queensland, Australia, 4215